AIDS News and Research

RSS

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

In an effort that will contribute to raising the quality of medicines in the Philippines and surrounding regions, the Laboratory Services Division (LSD) of the Philippine Food and Drug Administration (FDA) has attained the internationally recognized accreditation for testing and calibration laboratories, International Organization for Standardization/ International Electrotechnical Commission (ISO/IEC) 17025:2005.

13 Jul 2010

Former presidents endorse the Vienna Declaration

Former presidents Fernando Henrique Cardoso (Brazil), Ernesto Zedillo (M-xico) and C-sar Gaviria (Colombia) today announced their endorsement of the Vienna Declaration, the official declaration of the XVIII International AIDS Conference (AIDS 2010, www.aids2010.org) taking place from 18 to 23 July 2010.

13 Jul 2010

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

Under an agreement announced today by the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services, individuals who are deaf or hard of hearing will be provided equal access to a nursing and rehabilitation facility in New York State and will be provided interpretation services when necessary for effective communication.

13 Jul 2010

First Edition: July 13, 2010

Today's health policy headlines include a report about state preparations to cut Medicaid spending as the federal funding stalemate continues and a status check on the start up of high-risk pools.

13 Jul 2010

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

Advanced Biological Laboratories (ABL) is pleased to announce its recent signature of a non-exclusive international distribution agreement (excluding United States, Australia, Canada and United Kingdom) of virco®TYPE HIV-1, Belgium-based Virco BVBA's HIV resistance interpretation system.

13 Jul 2010

IAS, NIDA announce recipients of second annual joint research fellowships

The International AIDS Society (IAS) and the National Institute on Drug Abuse (NIDA) today announced the recipients of their second annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance the scientific understanding of the linkage between illicit drug use and HIV, while fostering multinational research.

13 Jul 2010

Studies suggest couple-based HIV/STD prevention interventions for African Americans

A risk reduction program focused on African American heterosexual couples appears to diminish risky sexual behaviors among couples in which one partner is HIV-positive and the other is not, according to a report posted online today that will appear in the September 27 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2010

Inadequate funding for research, prevention will not help eradicate HIV in Quebec

On the XVIII International AIDS Conference's Eve (Vienna, Austria, July 18th to 23rd 2010), Mark Wainberg, PhD, co-director at Réseau Sida/Maladies infectieuses (FRSQ) and Dr. Réjean Thomas, president of clinique médicale l'Actuel denounce chronic underfunding in research and prevention related to HIV in Quebec and it's dramatic impact on the HIV epidemic and STI's. Researchers insist that the government double the amounts dedicated to these sectors.

13 Jul 2010

AHF to criticize President Obama's NHAS in a press conference

AIDS Healthcare Foundation, the largest global AIDS organization, will host a press conference Tuesday, July 13th at 3:30 PM Eastern, to criticize President Obama's National HIV/AIDS Strategy which is being formally released in a White House press conference at 2pm Tuesday. The strategy, 15 months in the making, was crafted as the nation's AIDS Drug Assistance Program the federal and state funded, state run network of programs that supply lifesaving AIDS drugs to low-income Americans in need, collapsed.

13 Jul 2010

MD+DI survey names Crux Biomedical as one of "50 Companies to Watch"

Crux Biomedical® was named one of "50 Companies to Watch" in an annual survey of medical device and diagnostic companies. The survey, conducted by Medical Device and Diagnostics Industry (MD+DI), was published in its June 2010 issue. The purpose of the survey was to identify firms that have either achieved success or have the potential to revolutionize medical practice with their respective products.

13 Jul 2010

Tart cherry juice could help reduce severity of insomnia in older adults: Study

Drinking tart cherry juice daily could help reduce the severity of insomnia and time spent awake after going to sleep, according to a new study published in the Journal of Medicinal Food.

13 Jul 2010

Obama administration prepares to announce first national HIV strategy

Kaiser Health News: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic." Many HIV/AIDS advocates "say many more resources need to be committed to fight the disease, especially considering it doesn't get the attention it once did.

12 Jul 2010

Administration plans to release new HIV/AIDS strategy this week

Kaiser Health News staff writer Kate Steadman reports: "Federal officials plan to announce Tuesday a national strategy designed to ramp up and better coordinate the government's attack on the country's HIV/AIDS epidemic, an effort to deliver on a Barack Obama campaign promise delayed by the health care overhaul debate and other issues" (Steadman, 7/12).

12 Jul 2010

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

In an ideal world, Berwick would be Medicare's Winston Churchill, a prophetic voice who emerges from the wilderness and ends years of appeasement and denial. He tells the truth about federal health care and medicine generally. It's no wonder the Obama administration didn't think the Senate could handle it (Jay Hancock, 7/11).

12 Jul 2010

First Edition: July 12, 2010

Today's health policy headlines include previews of the expected release of a national strategy to curb the AIDS epidemic and reviews of a White House official's Sunday talk show defense of the Berwick nomination.

12 Jul 2010

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Julianna Lisziewicz, PhD, President of Genetic Immunity, a biopharmaceutical company developing nanomedicine-based immunotherapies, is an invited speaker at this week's 7th International Conference on Nanosciences & Nanotechnologies in Ouranoupolis Halkidiki, Greece. The conference gathers front-line researchers, scientists and industry experts specialized in nanotechnology applications. Leading experts such as Dr. Lisziewicz are invited to present lectures covering the latest research in this rapidly progressing field.

12 Jul 2010

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

"An effective vaccine against the AIDS virus may have moved one step closer to reality, researchers said Thursday," the Los Angeles Times reports. "Federal researchers have identified a pair of naturally occurring antibodies that are able to kill more than 90% of all strains of the AIDS virus, a finding they say could lead to the development of new treatments for HIV infections and to the production of the first successful vaccine against the virus" (Maugh, 7/9).

12 Jul 2010

Study examines impact of universal HIV testing, immediate ART program in Washington, DC

Implementing a program of universal HIV testing and immediate antiretroviral treatment for infected individuals could have a major impact on the HIV/AIDS epidemic in Washington, DC, but a new study finds that it would not halt the epidemic, something that a previous report had projected. In a paper that will appear in the August 15 issue of Clinical Infectious Diseases and has been released online, researchers find that the so-called "test-and-treat" strategy could reduce new HIV infections by 15 percent over the next five years while conferring large survival benefits to HIV-infected patients.

12 Jul 2010

World Bank announces new head for its HIV/AIDS program

"The World Bank on Thursday named David Wilson, a Zimbabwean national who has written extensively about AIDS in the developing world, to head the poverty-fighting institution's global HIV/AIDS program," Reuters reports.

12 Jul 2010

Science special section examines HIV/AIDS in Russia, Ukraine

In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."

12 Jul 2010

AIDS News and Research

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

Former presidents endorse the Vienna Declaration

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

First Edition: July 13, 2010

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

IAS, NIDA announce recipients of second annual joint research fellowships

Studies suggest couple-based HIV/STD prevention interventions for African Americans

Inadequate funding for research, prevention will not help eradicate HIV in Quebec

AHF to criticize President Obama's NHAS in a press conference

MD+DI survey names Crux Biomedical as one of "50 Companies to Watch"

Tart cherry juice could help reduce severity of insomnia in older adults: Study

Obama administration prepares to announce first national HIV strategy

Administration plans to release new HIV/AIDS strategy this week

Today's OpEds: Churchillian Berwick?; Government's obesity fight; WSJ on paying for health reform

First Edition: July 12, 2010

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

Study examines impact of universal HIV testing, immediate ART program in Washington, DC

World Bank announces new head for its HIV/AIDS program

Science special section examines HIV/AIDS in Russia, Ukraine

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News